Perio·Aid is the first antiseptic combination containing Chlorhexidine + Cetylpyridinium chloride, indicated as an adjuvant to the in-office treatment and control of periodontal and/or peri-implant disease.
Periodontal diseases, such as gingivitis and periodontitis, are generally considered chronic diseases that are infectious and inflammatory in nature, located in the tooth support tissues and which potentially cause the loss of teeth. Their primary cause is the accumulation of oral biofilm, both on the inner and the outer surfaces of the gums.
77.5% of caries initiate inside interproximal spaces. The difficulty to access these small areas during brushing, facilitates the accumulation of dental biofilm, aka, bacterial plaque, which causes most oral diseases including caries, gingivitis, peri-implant mucositis (in persons with implants), and disorders such as halitosis. This is one of the main messages presented at the first Interprox Open Day for journalists held in Madrid. [Leer más]
VITIS® continues to expand its product line for optimal daily oral hygiene by launching a new brush: VITIS® compact. Its reduced size makes it easy to always have on hand, without sacrificing the distinctive high quality of VITIS® brushes. [Leer más]
Periodontal and peri-implant diseases are becoming increasingly prevalent throughout society, and they are one of the main reasons people visit the dental office. They are also being studied worldwide for their possible implications in the development of other diseases such as diabetes and cardiovascular disease as well as complications including pre-term births.
For this reason, Perio·Aid® has launched an online venture called Perio·Expertise, whose aim is to gather scientific information on oral biofilm and its impact on periodontal and peri-implant health. [Leer más]